Latest Stories
Uncategorized
Qure.ai’s Chest X-Ray AI Wins Six New FDA Clearances, Taking the Crown in Radiology
Qure.ai's qXR-Detect just won six new FDA clearances for chest X-ray findings, becoming the first such tool cleared with a plan to keep updating its algorithm without a new filing each time.
Uncategorized
Novo Nordisk Bets on AWS and Agentic AI to Cut Years Off Drug Discovery
Novo Nordisk has named AWS its preferred cloud and AI partner and opened a co-innovation hub in London, using tools like Amazon Bio Discovery and Bedrock to try to compress the path from drug target to first human dose, part of a broader wave of pharma-hyperscaler AI deals.
Uncategorized
Oracle’s New AI Patient Portal Explains Your Cholesterol Trends in Plain English
Oracle Health's AI-powered patient portal, now generally available across the US, lets patients ask plain-language questions about labs, medications and diabetes management directly from their EHR, with citations and highlighting meant to keep AI answers traceable rather than opaque.
Uncategorized
OpenAI Foundation Commits $125 Million to Fix AI’s Biggest Health Data Gap
The OpenAI Foundation is putting $125 million into Public Data for Health, funding open scientific datasets at UNC's cancer center, OpenADMET and CTD Commons in a bet that better biological data, not just bigger models, is the real bottleneck for AI in medicine.
In-Depth
Uncategorized
OpenEvidence Rolls Out a Family of Medical AI Models, Keeps Its Perfect-MedQA-Score Model Under Wraps
OpenEvidence, used daily by more than 40% of U.S. physicians, split its clinical AI chatbot into three named models for speed and depth while holding back a fourth, Darwin, which it says scored perfectly on the MedQA benchmark, citing dual-use safety risks.
Uncategorized
Elucid Raises $55 Million to Push AI Heart-Plaque Imaging Into Mainstream Cardiology
Elucid closed a $55 million Series D on September 2, 2026, bringing total funding to about $185 million to expand its FDA-cleared Plaque-IQ AI, which reads coronary CT scans to classify dangerous heart plaque, plus a new FFR-CT tool awaiting FDA review.
Uncategorized
FDA Lets Four AI Health Tools Skip Pre-Market Approval to Reach Medicare Patients First
The FDA's new TEMPO pilot lets four generative-AI health tools, from SonderMind, Limbic, Cadence and Dexcom, reach Medicare patients before they receive full marketing authorization, trading pre-market review for real-world outcomes data on chronic conditions like depression, hypertension and prediabetes.
Uncategorized
Google and Character.AI Settle Lawsuits Over Teen Deaths Linked to Chatbot Relationships
Google and Character.AI settled five lawsuits, including the Sewell Setzer III wrongful-death case, alleging AI companion chatbots contributed to harm and death among teenagers.
Uncategorized
MyFitnessPal’s New AI Nutrition Coach Arrives as Study Finds Calorie-Photo Apps Are Often Wrong by 345 Calories
MyFitnessPal launched an AI Nutrition Coach built on its Cal AI acquisition, just as a NUTRITION 2026 study found AI calorie-photo apps average a 345-calorie estimation error.
